GlassScriptPhysician profile
Morgan M Sanchez
NPI 1588022651
$3,916.51
in general payments reported to CMS, 2019-2025
21 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $524 · 2023: $312 · 2024: $2,408 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,254 · Travel and Lodging: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,254.35 |
| Travel and Lodging | $939.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,817.96 | 2022-2024 | Seamguard, Gore Tag Thoracic Endoprosthesis, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Davol INC. | $311.45 | 2024 | Phasix Mesh |
| Novo Nordisk INC | $303.13 | 2021-2025 | Wegovy |
| Medical Device Business Services, INC. | $222.49 | 2022 | |
| Sk Life Science, INC. | $107.34 | 2024 | Xcopri |
| Corcept Therapeutics | $103.84 | 2025 | Korlym |
| United Therapeutics Corporation | $102.83 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $102.58 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $102.58 | 2022 | |
| Abbott Laboratories | $100.80 | 2023 | Freestyle Libre 3 |
| Aimmune Therapeutics, INC. | $99.81 | 2024 | |
| Sage Therapeutics, LLC | $91.69 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $88.43 | 2022 | |
| Intuitive Surgical, INC. | $76.20 | 2023-2025 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $68.37 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $51.74 | 2022-2025 | Linx Reflux Management System |
| Teleflex LLC | $40.87 | 2023 | Quikclot |
| Smith+Nephew, INC. | $40.56 | 2022 | |
| Alnylam Pharmaceuticals INC. | $33.53 | 2023 | Givlaari |
| Mimedx Group, INC. | $25.38 | 2025 | |
| Kci USA, INC. | $24.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.